[Pathogenetic therapy of multiple sclerosis].
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D045930:Anabolic Agents / Q000627:therapeutic use; D000975:Antioxidants / Q000627:therapeutic use; D001803:Blood Transfusion; D006801:Humans; D007167:Immunotherapy; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000628:therapy*; D011619:Psychotropic Drugs / Q000627:therapeutic use; D013934:Thymectomy; D014665:Vasodilator Agents / Q000627:therapeutic use; D014815:Vitamins / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D045930:Anabolic Agents; D000975:Antioxidants; D011619:Psychotropic Drugs; D014665:Vasodilator Agents; D014815:Vitamins
Patogeneticheskaia terapiia rasseiannogo skleroza.